Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir for severe periodontitis progression prevention
IRCT20230519058230N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in periodontitis comparing Valacyclovir plus scaling and root planing with Placebo plus scaling and root planing (2 arms). Primary endpoints: Probe depth, Bleeding on probing and 2 more. Started May 2023; status: completed.
02
Drugs
valaciclovir
03
Conditions
periodontitis
Beyond the preview
Go deeper on IRCT20230519058230N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230519058230N1.